Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Short-Term Bond · Advisors

Medalist Partners Short Duration Fund Investor Class (SEMRX)

Ticker SEMRX · Since 2010-12-23 · · Holdings as of May 31, 2026

Expense ratio
0.86%$86/yr per $10k
5-yr return
+4.6%annualized
1-yr return
+6.4%as of Dec 2025
Net assets
$581.5Mall share classes
Holdings
185

Bottom line

Is SEMRX a good fund? The bottom line

SEMRX is the Investor Class share class of Medalist Partners Short Duration Fund, a managed short-term bond mutual fund from Advisors.

Annual fees run 0.86% — about $86 a year on every $10,000 invested, more expensive than 83% of short-term bond funds we track.

It returned +6.4% over one year, +4.6% a year over five years, +3.2% a year over ten (as of Dec 31, 2025, per its prospectus).

With $581 million in net assets and 185 holdings, its largest position is First American Government Obli (2.3%) and the top 10 make up 16% of the portfolio.

What stands out

  • 5-year return beat 99% of category peers

What to watch

  • Expensive for its category (0.86%)
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What SEMRX invests in

The Short Duration Fund seeks to provide a high level of current income that is consistent with preservation of capital.

Under normal market conditions, the Short Duration Fund invests primarily in investment-grade debt securities of domestic entities. The Adviser considers securities to be of investment grade quality if they are rated BBB (or comparable) or higher by a nationally recognized credit rating organization including S&P Global Ratings (S&P) and Moodys Investors Service, Inc. (Moodys), or if unrated, determined by the Adviser to be of comparable quality. The Fund may hold securities that, after being purchased, are downgraded to non-investment grade and would no longer qualify for initial investment. Under normal circumstances, the Fund expects to maintain a weighted average portfolio duration of up to three years. The Fund defines duration as effective duration which is the interest rate sensitivity of projected cash flows from Fund securities, adjusted for amortization, prepayments, and…

From the fund's prospectus (filed Mar 27, 2026).

SEMRX performance

Average annual total returns
1 yr5 yr10 yr
SEMRX+6.4%+4.6%+3.2%
Short-Term Bond median+5.2%+2.2%+2.3%

Source: Fund prospectus, as of Dec 31, 2025

Full SEMRX performance history →

What SEMRX costs

On a $10,000 investment, SEMRX's 0.86% expense ratio costs about $86 a year. The prospectus estimates $1,050 in total costs over 10 years (assuming 5% annual returns). The median short-term bond fund charges 0.47%.

See the full SEMRX fee table →

SEMRX top 10 holdings

#Holding% of fund
1First American Government Obli2.28%
2Pagaya AI Debt Selection Trust1.86%
3Point Securitization Trust1.71%
4Pagaya AI Debt Selection Trust1.61%
5Cerberus1.60%
6COLEM 2021-HLNE Mortgage Trust1.46%
7Morgan Stanley Capital I Trust1.44%
8Comvest Credit CLO1.37%
9Freddie Mac1.33%
10Freddie Mac - STACR1.31%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 16% of the fund. See all top 25 holdings and asset mix →

Alternatives to SEMRX

More funds like SEMRX →

SEMRX FAQ

What is the expense ratio of SEMRX?
SEMRX's expense ratio is 0.86%, which works out to about $86 a year for every $10,000 invested. The prospectus estimates total costs of $1,050 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is SEMRX a good investment?
It depends on your goals, but the data points to: 5-year return beat 99% of category peers; expensive for its category (0.86%); 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does SEMRX hold?
SEMRX's largest holdings are First American Government Obli (2.3%), Pagaya AI Debt Selection Trust (1.9%), Point Securitization Trust (1.7%), Pagaya AI Debt Selection Trust (1.6%), Cerberus (1.6%). It holds 185 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is SEMRX's 5-year return?
SEMRX returned +4.6% a year over the five years ending Dec 31, 2025, and +3.2% a year over ten years. Past performance does not guarantee future results.
Who manages SEMRX?
SEMRX is offered by Advisors through Advisors Series Trust.